Citadel Advisors’s Affimed AFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding AFMD
6CM
NMC
TCM
IP
NFGH
Citadel Advisors's AFMD Position: Q1 2025 in Review
Citadel Advisors sold out of Affimed (AFMD) in Q1 2025, closing a stake of 114,774 shares — an estimated $137K sold.
Citadel Advisors first reported a position in AFMD in Q2 2015 and held it in 26 quarters. The position peaked at $37.2M in Q2 2021. 29 funds tracked by Wall St. Rank hold AFMD as of Q1 2025.
- Citadel Advisors reported no remaining Affimed position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 114,774 Affimed shares in Q1 2025, an estimated $137K.
- Citadel Advisors first reported a position in Affimed in Q2 2015 and held it in 26 quarters.
- Citadel Advisors's Affimed position peaked at $37.2M in Q2 2021.
- 29 funds tracked by Wall St. Rank held Affimed as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.